In the news
AlphaGenome 2: Deciphering how cells read DNA to better understand disease
Google DeepMind · Published · 3 min read
In 30 seconds
- What happened
- Google DeepMind released AlphaGenome 2, an AI model predicting how DNA variants affect gene expression in specific human cell types, improving variant detection nearly twofold.
- Why it matters
- Biomedical researchers studying disease mechanisms, genetic variants, and drug discovery need better tools linking genome-wide association findings to actual cellular effects.
- Watch out
- The model is research-only, not validated for clinical use. It requires careful interpretation and cannot replace experimental validation of predicted variant effects.
The patterns behind this
- Agent Registry & Discovery
- MMAU: Massive Multitask Agent Understanding
- Structured Reflection (Think Tool)
Each one covers how the technique works, when it earns its cost, and where it breaks.
The Agent Architect
One pattern, one tradeoff, one production failure story. A short weekly briefing for people building agentic systems.
Weekly email, one-click unsubscribe. We only use your address to send the briefing.